ATE363474T1 - Benzimidazole zur behandlung sexueller fehlfunktionen - Google Patents
Benzimidazole zur behandlung sexueller fehlfunktionenInfo
- Publication number
- ATE363474T1 ATE363474T1 AT02731130T AT02731130T ATE363474T1 AT E363474 T1 ATE363474 T1 AT E363474T1 AT 02731130 T AT02731130 T AT 02731130T AT 02731130 T AT02731130 T AT 02731130T AT E363474 T1 ATE363474 T1 AT E363474T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- benzimidazole
- sexual difficulties
- sexual
- difficulties
- Prior art date
Links
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title 1
- 230000001568 sexual effect Effects 0.000 title 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Discharging, Photosensitive Material Shape In Electrophotography (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80353701A | 2001-03-09 | 2001-03-09 | |
| US09/874,484 US20030008878A1 (en) | 2001-03-09 | 2001-06-05 | Benzimidazoles that are useful in treating sexual dysfunction |
| US10/017,939 US20020169166A1 (en) | 2001-03-09 | 2001-12-14 | Benzimidazoles that are useful in treating sexual dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE363474T1 true ATE363474T1 (de) | 2007-06-15 |
Family
ID=27360930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02731130T ATE363474T1 (de) | 2001-03-09 | 2002-03-06 | Benzimidazole zur behandlung sexueller fehlfunktionen |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20020169166A1 (de) |
| EP (1) | EP1373220B1 (de) |
| JP (1) | JP2005507370A (de) |
| CN (1) | CN100430383C (de) |
| AT (1) | ATE363474T1 (de) |
| AU (1) | AU2002303128B2 (de) |
| BG (1) | BG108230A (de) |
| BR (1) | BR0205812A (de) |
| CA (1) | CA2439943A1 (de) |
| CZ (1) | CZ20032659A3 (de) |
| DE (1) | DE60220385T2 (de) |
| DK (1) | DK1373220T3 (de) |
| ES (1) | ES2287278T3 (de) |
| HU (1) | HUP0303413A3 (de) |
| IL (1) | IL157457A0 (de) |
| MX (1) | MXPA03008151A (de) |
| NO (1) | NO326686B1 (de) |
| NZ (1) | NZ527713A (de) |
| PL (1) | PL371272A1 (de) |
| SK (1) | SK12612003A3 (de) |
| UY (1) | UY27203A1 (de) |
| WO (1) | WO2002088093A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7022728B2 (en) * | 2001-03-09 | 2006-04-04 | Abbott Laboratories | Benzimidazoles that are useful in treating male sexual dysfunction |
| US6960589B2 (en) * | 2001-03-09 | 2005-11-01 | Abbott Laboratories | Benzimidazoles that are useful in treating sexual dysfunction |
| US20040127504A1 (en) * | 2002-09-06 | 2004-07-01 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
| EP2316825A1 (de) * | 2003-07-30 | 2011-05-04 | Xenon Pharmaceuticals Inc. | Pyridyl Derivate und deren Verwendung als therapeutische Wirkstoffe |
| NZ545265A (en) | 2003-07-30 | 2009-11-27 | Xenon Pharmaceuticals Inc | Pyridazine derivatives and their use for treating diseases mediated by stearoyl-CoA desaturase (SCD) enzymes |
| AR045496A1 (es) * | 2003-08-29 | 2005-11-02 | Schering Corp | Analolgos de benzimidazolpiperidinas 2- substiyuidas como antagonistas de los receptores de la hormona que concentra melanina selectivos para el tratamiento de la obesidad y trastornos relacionados |
| US8071603B2 (en) | 2004-09-20 | 2011-12-06 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| BRPI0515482A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e seus usos como agentes terapêuticos |
| MX2007003327A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa. |
| CA2580855A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| WO2006034341A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| TW200626138A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| AR051026A1 (es) | 2004-09-20 | 2006-12-13 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa |
| US8541457B2 (en) | 2005-06-03 | 2013-09-24 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors |
| WO2008079945A2 (en) * | 2006-12-20 | 2008-07-03 | University Of South Florida | Rock inhibitors and uses thereof |
| EP2149373A1 (de) * | 2008-08-01 | 2010-02-03 | Laboratorios Del. Dr. Esteve, S.A. | 5HT7-Rezeptorliganden und Zusammensetzungen damit |
| EP2545905A1 (de) | 2011-07-11 | 2013-01-16 | Britannia Pharmaceuticals Limited | Neue therapeutische Zusammensetzung mit Apomorphin als aktiver Inhaltsstoff |
| KR102314286B1 (ko) * | 2016-12-16 | 2021-10-21 | 화이자 인코포레이티드 | Glp-1 수용체 작용제 및 이의 용도 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
| FR2665161B1 (fr) * | 1990-07-26 | 1992-11-27 | Esteve Labor Dr | Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments. |
| GB9306578D0 (en) * | 1993-03-30 | 1993-05-26 | Merck Sharp & Dohme | Therapeutic agents |
| HUP9900625A3 (en) * | 1995-12-28 | 2003-04-28 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds |
| GB9700878D0 (en) * | 1997-01-17 | 1997-03-05 | Scherer Ltd R P | Dosage forms and method for ameliorating male erectile dysfunction |
| CA2251255A1 (en) * | 1998-10-20 | 2000-04-20 | Mcgill University | The use of dopaminergic agents in the management of sexual dysfunction |
| ES2154605B1 (es) * | 1999-09-14 | 2001-11-16 | Univ Madrid Complutense | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 |
-
2001
- 2001-12-14 US US10/017,939 patent/US20020169166A1/en not_active Abandoned
-
2002
- 2002-03-06 ES ES02731130T patent/ES2287278T3/es not_active Expired - Lifetime
- 2002-03-06 BR BR0205812-0A patent/BR0205812A/pt not_active IP Right Cessation
- 2002-03-06 AU AU2002303128A patent/AU2002303128B2/en not_active Ceased
- 2002-03-06 EP EP02731130A patent/EP1373220B1/de not_active Expired - Lifetime
- 2002-03-06 WO PCT/US2002/007791 patent/WO2002088093A1/en not_active Ceased
- 2002-03-06 DE DE60220385T patent/DE60220385T2/de not_active Expired - Lifetime
- 2002-03-06 DK DK02731130T patent/DK1373220T3/da active
- 2002-03-06 NZ NZ527713A patent/NZ527713A/en unknown
- 2002-03-06 JP JP2002585395A patent/JP2005507370A/ja active Pending
- 2002-03-06 CA CA002439943A patent/CA2439943A1/en not_active Abandoned
- 2002-03-06 CN CNB028093828A patent/CN100430383C/zh not_active Expired - Fee Related
- 2002-03-06 MX MXPA03008151A patent/MXPA03008151A/es active IP Right Grant
- 2002-03-06 IL IL15745702A patent/IL157457A0/xx unknown
- 2002-03-06 AT AT02731130T patent/ATE363474T1/de not_active IP Right Cessation
- 2002-03-06 SK SK1261-2003A patent/SK12612003A3/sk not_active Application Discontinuation
- 2002-03-06 CZ CZ20032659A patent/CZ20032659A3/cs unknown
- 2002-03-06 PL PL02371272A patent/PL371272A1/xx not_active Application Discontinuation
- 2002-03-06 HU HU0303413A patent/HUP0303413A3/hu unknown
- 2002-03-11 UY UY27203A patent/UY27203A1/es not_active Application Discontinuation
-
2003
- 2003-09-08 NO NO20033959A patent/NO326686B1/no not_active IP Right Cessation
- 2003-10-03 BG BG108230A patent/BG108230A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1062174A1 (en) | 2004-10-21 |
| BG108230A (bg) | 2005-04-30 |
| NZ527713A (en) | 2006-09-29 |
| CA2439943A1 (en) | 2002-11-07 |
| EP1373220B1 (de) | 2007-05-30 |
| HUP0303413A3 (en) | 2007-08-28 |
| UY27203A1 (es) | 2002-10-31 |
| NO20033959D0 (no) | 2003-09-08 |
| HUP0303413A2 (hu) | 2004-01-28 |
| CZ20032659A3 (cs) | 2004-01-14 |
| CN1516693A (zh) | 2004-07-28 |
| DE60220385T2 (de) | 2008-04-03 |
| EP1373220A1 (de) | 2004-01-02 |
| BR0205812A (pt) | 2005-05-03 |
| IL157457A0 (en) | 2004-03-28 |
| NO326686B1 (no) | 2009-01-26 |
| DK1373220T3 (da) | 2007-10-08 |
| WO2002088093A1 (en) | 2002-11-07 |
| SK12612003A3 (sk) | 2004-04-06 |
| AU2002303128B2 (en) | 2007-11-29 |
| DE60220385D1 (de) | 2007-07-12 |
| MXPA03008151A (es) | 2004-03-16 |
| US20020169166A1 (en) | 2002-11-14 |
| NO20033959L (no) | 2003-11-10 |
| JP2005507370A (ja) | 2005-03-17 |
| ES2287278T3 (es) | 2007-12-16 |
| CN100430383C (zh) | 2008-11-05 |
| PL371272A1 (en) | 2005-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE363474T1 (de) | Benzimidazole zur behandlung sexueller fehlfunktionen | |
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
| EA200201247A1 (ru) | Соединения для лечения болезни альцгеймера | |
| DE60116313D1 (de) | Verbindungen zur behandlung der alzheimerischen krankheit | |
| TW200505903A (en) | CGRP receptor antagonists | |
| MXPA02011425A (es) | Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa. | |
| DE602004013563D1 (de) | Rantagonisten | |
| EP1615914A4 (de) | Cgrp-rezeptorantagonisten | |
| ATE396973T1 (de) | Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit | |
| DE60214179D1 (de) | IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN | |
| ATE517861T1 (de) | Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| BG66080B1 (bg) | Заместени тиоацетамиди | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| GB0127903D0 (en) | Improvements relating to organic compounds | |
| PL376324A1 (en) | Piperazinyl and diazapanyl benzamides and benzthioamides | |
| BR0305708A (pt) | Derivados de benzimidazol para o tratamento de disfunção sexual | |
| DK1315506T3 (da) | Phospholipidderivater af valproinsyre og blandinger deraf | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| ATE432278T1 (de) | Verbindungen zur behandlung von krankheiten | |
| ATE432936T1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
| ATE536874T1 (de) | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen | |
| DE60204014D1 (de) | Chlormethylierung von thiophene | |
| DE60326348D1 (de) | Makrozyclen zur behandlung von krebserkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1373220 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |